Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Pharmaceuticals has received final approval from the FDA for its abbreviated new drug application for terbinafine hydrochloride tablets, in a 250mg dose.
Subscribe to our email newsletter
Terbinafine HCl Tablets are the generic version of Novartis’ Lamisil tablets, which are used for fungal infections.
Terbinafine HCl tablets had US sales of approximately $685 million for the 12 months ending March 31, 2007, for the same strength, according to the company.
The product will be shipped immediately.